Inspection Record

Celltrion Healthcare Canada Limited — Health Canada Inspection Findings

Health CanadaInspected 2025-11-12 5 findingsRegulatory reporting and change controlOther quality systemComplaint and recall handlingDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

2Other quality system

The written self-inspection procedure was inadequate.

3Complaint and recall handling

The quality control department's handling of complaints and/or information received about drug quality was inadequate.

4Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

5Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate. The controls put in place for electronic signatures were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-11-12. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Celltrion Healthcare Canada Limited company profile — full history Health Canada documents, 2025 Go to Findings search